Please guarantee Javascript is enabled for functions ofweb site accessibilityMan celebrates birthday kayaking, biking, and mountaineering 106 miles for breast most cancers survivorsWed,...
Roche Korea has renewed its bid for medical insurance protection of its anti-PD-L1 immuno-oncology drug Tecentriq (atezolizumab) as an adjuvant remedy after surgical...
The FDA has awarded a quick monitor designation to ADI-270 for the potential therapy of sufferers with metastatic/superior clear cell renal cell carcinoma...